The global methicillin-resistant Staphylococcus aureus (MRSA) drugs market is positioned for steady expansion, supported by the increasing occurrence of antibiotic-resistant bacterial infections and the growing need for effective treatment options across healthcare settings. Staphylococcus aureus is commonly found on the skin and in the nose of healthy individuals, while MRSA represents strains...
